Asim Mantarcı

Asim Mantarcı

Auto-generated profile, based on publicly available information

Asim Mantarcı

Muş Alparslan Üniversitesi

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2019 in Research on Chemical Intermediates
Verified
Journal Article
Closed access
PDF file
KBKenan BULDURUN
Kenan BULDURUN
NTNevin Turan
Nevin Turan
Ercan BursalErcan Bursal
Ercan Bursal
AMAsim Mantarcı
Asim Mantarcı
FTFikret Turkan
Fikret Turkan
Ilhami GulcinIlhami Gulcin
Ilhami Gulcin

5 August 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
KBKenan BULDURUN
Kenan BULDURUN
NTNevin Turan
Nevin Turan
Ercan BursalErcan Bursal
Ercan Bursal
AAAbdulmelik Aras
Abdulmelik Aras
AMAsim Mantarcı
Asim Mantarcı
Ilhami GulcinIlhami Gulcin
Ilhami Gulcin
The Schiff base ligand ((E)-6-methyl-2-(2,3,4-trimethoxybenzylideneamino)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carbonitrile) and its cobalt(II) and palladium(II) complexes were successfully prepared. The structure of the compounds was elucidated by various techniques (NMR, FT-IR, powder X-ray diffraction, microanalysis, TGA, magnetic susceptibility, mass spectrometry). The Pd(II) complex showed a square planar geometry and the Co(II) complex had an octahedral geometry. ABTS (2,2-azino-bis 3-ethylbenzothiazloine-6-sulphonic acid), DPPH (1,1-diphenyl-2-picrylhydrazyl), FRAP (ferric-reducing antioxidant power) and CUPRAC (cupric reducing antioxidant capacity) in vitro methods were applied to identify the antioxidant features of the synthesized compounds. In addition, glutathione S-transferase and acetyl/butyryl cholinesterase enzymes were examined for possible inhibition capacities of the complexes. According to the enzyme activity measurements, Ru(II) complex inhibited both GST and BChE enzymes, while Fe(II) complex inhibited only AChE enzyme. Furthermore, the antioxidant activities and enzyme inhibitions of the previously synthesized Fe(II) and Ru(II) complexes of the same ligand were examined to make a comparison of the metal complexes. Communicated by Ramaswamy H. Sarma

17 June 2019 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
KBKenan BULDURUN
Kenan BULDURUN
NTNevin Turan
Nevin Turan
AAAbdulmelik Aras
Abdulmelik Aras
AMAsim Mantarcı
Asim Mantarcı
FTFikret Turkan
Fikret Turkan
Ercan BursalErcan Bursal
Ercan Bursal

30 November 2020 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
MAMehmet Eşref ALKIŞ
Mehmet Eşref ALKIŞ
KBKenan BULDURUN
Kenan BULDURUN
NTNevin Turan
Nevin Turan
YAYusuf Alan
Yusuf Alan
ÜYÜnzile Keleştemur Yılmaz
Ünzile Keleştemur Yılmaz
AMAsim Mantarcı
Asim Mantarcı
In the study, a new Schiff base (ligand) was obtained using 4-aminopyrimidine-2(1H)-one, the starting material, and 2,3,4-trimethoxy benzaldehyde. Ni(II) and Pd(II) complexes were obtained from the reaction of the ligand and NiCl2·6H2O, PdCl2(CH3CN)2 (1:1 ratio). These compounds were characterized using the elemental and mass analysis, 1H, 13C-NMR, FT-IR, UV-Vis, magnetic susceptibility, thermal analysis, and the X-ray diffraction analyses. The antiproliferative activities of the synthesized ligand, Ni(II) and Pd(II) complexes were identified on the HepG2 (human liver cancer cells) cell line and their biocompatibility was tested on the L-929 (fibroblast cells) cell line by the MTT analysis method. Furthermore, the effects of electroporation (EP) on the cytotoxic activities of synthesized compounds were investigated in HepG2 cancer cells. According to the MTT findings of the study, the ligand did not exhibit an antiproliferative activity while its Ni(II) and Pd(II) complexes exhibited an antiproliferative activity. Moreover, it was observed that the antiproliferative activity of the Pd(II) complex was stronger than that of the Ni(II) complex. The combined application of EP + compounds is much more effective than the usage of the compounds alone in the treatment of HepG2 cancer cells. The EP increased the cytotoxicity of the Ni(II) and Pd(II) complexes by 1.66, and 2.54 times, respectively. It was concluded that Ni(II) and Pd(II) complexes may contribute as potential anti-cancer agents for the treatment of hepatocellular carcinoma and yield promising results in the case of being used in ECT. Communicated by Ramaswamy H. Sarma

19 June 2019 in Bulletin of Materials Science
Verified
Journal Article
Closed access
PDF file
AMAsım Mantarci
Asım Mantarci
MKMutlu Kundakçi
Mutlu Kundakçi